rps1202 Antibody

What is RPS12 and why is it important in cellular research?

RPS12 (ribosomal protein S12) is a plastid ribosomal protein that forms part of the 30S ribosomal subunit. It plays a crucial role in translational accuracy alongside ribosomal proteins S4 and S5. RPS12 is recognized as a 15 kDa protein that participates in the small subunit (SSU) processome, which is the first precursor of the small eukaryotic ribosomal subunit. During nucleolar SSU processome assembly, RPS12 works with other ribosome biogenesis factors and ribosomal proteins to facilitate RNA folding, modifications, rearrangements, and cleavage, as well as targeted degradation of pre-ribosomal RNA by the RNA exosome .

What species reactivity can I expect with commercially available RPS12 antibodies?

Most commercially available RPS12 antibodies have demonstrated reactivity with human, mouse, and rat samples. Some antibodies have also been cited for reactivity with Drosophila models. Always check the manufacturer's specifications for the particular antibody you're using, as reactivity can vary between products. For instance, the antibody cataloged as 16490-1-AP has been tested and confirmed for reactivity with human, mouse, and rat samples .

What are the common applications for RPS12 antibodies in research?

RPS12 antibodies can be used in multiple experimental applications including:

The antibody should be titrated in each testing system to obtain optimal results, as the appropriate dilution may be sample-dependent .

How should I optimize Western blot protocols for RPS12 detection?

For optimal Western blot results with RPS12 antibodies, prepare cell lysates using NETN lysis buffer and load approximately 50 μg of whole cell lysate per lane. A working concentration of approximately 0.04 μg/mL has been successful for detecting RPS12 in HeLa and HEK-293T cell lysates . Given the small size of RPS12 (15 kDa), use appropriate percentage gels (12-15%) for better resolution in the lower molecular weight range. Ensure proper transfer conditions for small proteins, potentially using PVDF membranes with 0.2 μm pore size rather than 0.45 μm. For blocking, 5% non-fat dry milk in TBST generally works well, but optimization may be needed based on your specific antibody .

What antigen retrieval methods are recommended for IHC with RPS12 antibodies?

For immunohistochemistry applications with RPS12 antibodies, antigen retrieval is typically performed using TE buffer at pH 9.0. Alternatively, citrate buffer at pH 6.0 may also be effective. The choice between these two methods may depend on your specific tissue samples and fixation conditions. After antigen retrieval, standard IHC protocols can be followed with RPS12 antibody dilutions ranging from 1:20 to 1:200, depending on the specific antibody and tissue being examined .

What controls should be included when validating a new RPS12 antibody?

When validating a new RPS12 antibody, include the following controls:

• Positive controls: Use cell lines with known RPS12 expression (NIH/3T3, HeLa, MCF-7, or HepG2 cells)

• Negative controls: Include samples where primary antibody is omitted

• Specificity controls: If available, use RPS12 knockout or knockdown samples

• Peptide competition assay: Pre-incubate antibody with immunizing peptide to confirm specificity

• Cross-reactivity assessment: Test multiple species if working across different model organisms

• Multiple detection methods: Validate using complementary techniques (WB, IF, IHC) to confirm specificity

How can I use RPS12 antibodies to investigate ribosome biogenesis in developmental contexts?

RPS12 antibodies can be valuable tools for studying ribosome biogenesis during development, particularly in contexts like early forebrain development where downregulation of ribosome biogenesis has been observed. Design your experiments to include developmental time points, using RPS12 antibodies in combination with other ribosomal markers. For developmental studies, immunofluorescence staining might be particularly useful to visualize spatial changes in expression. Recent publications have used RPS12 antibodies to investigate downregulation of ribosome biogenesis during early forebrain development and to analyze the proteome composition in amniotic fluid and cerebrospinal fluid following neural tube closure .

What are the considerations when using RPS12 antibodies for studying cancer cell biology?

When using RPS12 antibodies in cancer research, consider the following:

• Expression levels may vary significantly between cancer types and even within tumor samples

• Include appropriate non-cancer controls for meaningful comparisons

• Use IHC on tissue microarrays to efficiently screen multiple samples

• Consider dual staining with proliferation markers to correlate RPS12 expression with cell proliferation states

• Combine with functional assays to assess the impact of RPS12 on cancer cell behavior

• Be aware that changes in ribosome biogenesis are common in cancer, so interpretations should account for this context

Recent research has utilized RPS12 antibodies in studies involving colon cancer tissues and various cancer cell lines, including investigations of MYC-driven high-grade serous ovarian carcinomas .

What challenges might I encounter when detecting RPS12 in immunoprecipitation experiments?

Immunoprecipitation of RPS12 can present several challenges:

• Cross-reactivity with other ribosomal proteins due to structural similarities

• Determining optimal lysis conditions to maintain protein-protein interactions while efficiently extracting RPS12

• Distinguishing between free RPS12 and that incorporated into ribosomal complexes

• Need for gentle washing conditions to preserve interactions with binding partners

To overcome these challenges, use specialized lysis buffers (such as NETN buffer), adjust salt concentrations to control stringency, and consider crosslinking approaches if studying RPS12 interactions within intact ribosomes. Successful IP of RPS12 has been reported in HeLa cells using 0.5-4.0 μg of antibody for 1.0-3.0 mg of total protein lysate .

How can I distinguish between free RPS12 and RPS12 incorporated into ribosomes?

Distinguishing between free and ribosome-incorporated RPS12 requires specific experimental approaches:

• Sucrose gradient fractionation: Separate free proteins from ribosomal subunits, monosomes, and polysomes

• Size exclusion chromatography: Separate components based on size differences

• Differential centrifugation: Isolate cytosolic (containing free RPS12) and ribosomal fractions

• Immunofluorescence with co-localization studies: Use nucleolar markers to identify pre-ribosomal RPS12

• Proximity ligation assays: Detect RPS12 interactions with other ribosomal components

The RAPIDASH (tag-free enrichment of ribosome-associated proteins) approach has been used in recent research to analyze the composition dynamics of ribosome-associated proteins in various contexts, including embryonic tissues, cancer cells, and macrophages .

What roles does RPS12 play in axonal translation, and how can antibodies help investigate this?

RPS12 has been implicated in localized translation in neuronal axons. When studying this phenomenon, RPS12 antibodies can be used for:

• Co-localization studies with axonal markers and translation machinery components

• Proximity ligation assays to detect RPS12 interactions with axon-specific translation factors

• Immunoprecipitation followed by RNA-seq to identify mRNAs associated with RPS12-containing ribosomes in axons

• Puromycin incorporation assays combined with RPS12 staining to visualize active translation sites

Recent research has revealed that axonal endoplasmic reticulum tubules control local translation via P180/RRBP1-mediated ribosome interactions, and RPS12 antibodies have been instrumental in these studies .

How should I interpret seemingly contradictory RPS12 localization data between techniques?

When faced with contradictory RPS12 localization data:

• Consider fixation artifacts: Different fixation methods can affect epitope accessibility and apparent localization

• Evaluate antibody specificity: Confirm specificity through knockout controls or using multiple antibodies targeting different epitopes

• Assess cell cycle effects: RPS12 localization may change throughout the cell cycle

• Account for cellular stress responses: Stress can trigger redistribution of ribosomal proteins

• Compare detection sensitivities: IF might not detect low abundance populations visible by more sensitive techniques

• Examine extraction methods: Some protocols may selectively extract certain pools of RPS12

When publishing such data, clearly document all methodological details and acknowledge the limitations of each technique to facilitate proper interpretation by the scientific community .

How does the performance of RPS12 antibodies compare to antibodies against other ribosomal proteins?

When comparing RPS12 antibodies to those targeting other ribosomal proteins:

• Specificity: RPS12 antibodies typically show high specificity comparable to other well-characterized ribosomal protein antibodies

• Cross-reactivity: Like many ribosomal protein antibodies, RPS12 antibodies often work across multiple species due to high conservation

• Application versatility: RPS12 antibodies perform well in multiple applications (WB, IP, IHC, IF) similar to antibodies against S4 and S5

• Signal-to-noise ratio: Generally comparable to other ribosomal protein antibodies when used at optimized concentrations

• Epitope accessibility: May require specific buffer conditions to access epitopes in intact ribosomal structures

When designing multi-parameter studies, RPS12 antibodies can be effectively paired with antibodies against other ribosomal proteins to investigate different aspects of ribosome structure and function .

What are the advantages of using polyclonal versus monoclonal RPS12 antibodies in different research applications?

The choice between polyclonal and monoclonal RPS12 antibodies depends on your specific research needs:

The commercially available RPS12 antibodies mentioned in the search results (16490-1-AP and ab226358) are polyclonal antibodies, which offer the advantage of recognizing multiple epitopes and providing robust detection in various applications .

How can RPS12 antibodies contribute to understanding specialized ribosomes and their role in disease?

RPS12 antibodies can play a crucial role in investigating specialized ribosomes:

• Use for differential proteomic analysis of ribosomes in normal versus disease states

• Employ for spatial mapping of specialized ribosome populations within complex tissues

• Apply in multiplex staining to correlate RPS12 incorporation with specific translation events

• Utilize for tracking ribosome specialization during cellular differentiation

• Implement in studies of how ribosome composition affects selective mRNA translation

Recent research has employed RPS12 antibodies to investigate functional screens identifying RBM42 as a mediator of oncogenic mRNA translation specificity, suggesting an important role for RPS12-containing ribosomes in cancer biology. Future studies may use these antibodies to explore ribosome specialization in neurodevelopmental disorders and other diseases .

What emerging technologies might enhance the utility of RPS12 antibodies in studying ribosome dynamics?

Several emerging technologies could enhance RPS12 antibody applications:

• Super-resolution microscopy to visualize ribosome distributions at nanoscale resolution

• Single-molecule imaging to track RPS12-containing ribosomes in real-time

• Mass cytometry (CyTOF) combining RPS12 antibodies with dozens of other markers

• Spatial transcriptomics integrated with RPS12 immunostaining to correlate ribosome location with specific translated mRNAs

• Expansion microscopy to physically enlarge samples for improved visualization of ribosomal structures

• Cryo-electron tomography correlated with immunogold labeling of RPS12

These approaches could provide unprecedented insights into how RPS12-containing ribosomes contribute to specialized translation events in development, disease, and cellular stress responses .